Promise of Fast Growth Propels Molecular Technologies in Fighting Infections

Promise of Fast Growth Propels Molecular Technologies in Fighting Infections

Molecular infectious disease tests detect active and latent patient infections by targeting genetic sequences specific to pathogens, typically bacteria or viruses, but also fungi and parasites. Tests that utilize these methods experience faster revenue growth and will compete better on the world market, according to Kalorama's recent study on the molecular infectious disease testing market.


Molecular Diagnostics Faces Competition for Future Point of Care Testing in Developing World

Molecular Diagnostics Faces Competition for Future Point of Care Testing in Developing World

The sensitivity and specificity of nucleic acid analytes provide molecular diagnostics key advantages in clinical practice, particularly in critical health situations. Nucleic acid amplification (NAATs) or molecular tests are now open to routine and distributed use in healthcare thanks to advancements in microfluidics and molecular reagents. As molecular diagnostics enter point-of-care (POC) settings, cost becomes a key issue in comparison to predominantly used and cheaply performed rapid immunoassays.


What are the Growth Markets in the Hospital Infection Control Industry?

What are the Growth Markets in the Hospital Infection Control Industry?

The scourge of hospital-acquired-infections (HAIs) will drive market growth for infection control in three segments. Devices that can test for HAIs, equipment to clean and sterilize facilities and devices, and drugs that can treat these threats.


New Therapies, Risk Factors Drive Hepatitis C Diagnostics

New Therapies, Risk Factors Drive Hepatitis C Diagnostics

This blog post discusses findings from Kalorama Information’s just-published market research report, The World Market for Molecular Diagnostics, 7th Edition (Infectious Disease, Cancer, NAT Blood Screening, Transplantation, Histology/Cytology, Inherited Diseases).

Clinical molecular diagnostics does not lack in targets. Dynamic expansion markets in point-of-care testing and cancer have headlined assay development efforts in recent years, but they are not the only major opportunities in molecular diagnostics.


Healthcare Turns to Mass Spectrometry to Combat Infectious Disease

Healthcare Turns to Mass Spectrometry to Combat Infectious Disease

The concept of breaking down compounds, charging or ionizing them, in order to determine their properties, or mass spectrometry, is a technology first developed several decades ago and cofinded deep in research laboratories. Now it’s becoming as important a testing tool and other in vitro diagnostic analyzers. New improvements in the old technology such as laser desorption and electrospray have made these machines usable for protein and DNA work, and innovative companies have put them to work combating disease threats such as cancer and infectious disease.


Quest and DiaSorin to Focus on Key Markets Following Acquisition Deal

Quest and DiaSorin to Focus on Key Markets Following Acquisition Deal

This blog post reviews aspects of DiaSorin’s acquisition of Focus Diagnostics from Quest Diagnostics that are relevant to markets reviewed in Kalorama Information reports The World Market for Infectious Disease Diagnostic Tests , Clinical Laboratory Services Market , and Mergers and Acquisitions in the IVD Market.

At the end of March, Quest Diagnostics and DiaSorin S.p.A. announced the latter’s acquisition of Quest subsidiary Focus Diagnostics, Inc. for $300 million. The deal assists Quest Dia...